Clinical Treatment Experience in Severe and Critical COVID-19

Clinical Treatment Experience in Severe and Critical COVID-19

Compared with other deadly diseases, the coronavirus disease 2019 (COVID-19) is highly infectious with a relatively low mortality rate. Although critical cases account for only 5% of cases, the mortality rate for the same is nearly 50%. Therefore, the key to the COVID-19 treatment is to effectively...

Full description

Saved in:
Bibliographic Details
Main Authors: Mingliang Li, Donglin Zhu, Jianghua Yang, Ling Yan, Zhiyong Xiong, Jiahai Lu, Xiaogang Bi, Yun Xi, Zeliang Chen
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2021/9924542
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items